On June 11, 2010 Senator Max Baucus, the United States Senator from Montana, received the Bruce Vento Hope Builder Award during the International Symposium on Malignant Mesothelioma. This event, hosted by the Mesothelioma Applied Research Foundation (Meso Foundation) took place in Washington, DC from June 10 – 12, 2010 at the Omni Shoreham Hotel. This year, nearly 300 mesothelioma patients, their families and friends, those who have lost a loved one to meso, researchers, and other professionals, convened at the Meso Foundation’s three-day conference to exchange scientific and medical updates, to network with other allies in the fight to cure mesothelioma, and to advocate Congress for allocation of funds for mesothelioma research.
The Bruce Vento Hope Builder Award, named for the late Minnesota Congressman who died from meso in 2000, acknowledges the support and initiatives of a political leader. Senator Max Baucus, whose state of Montana is home of Libby, a town contaminated by asbestos with first hand knowledge of its tragic effects, has been a champion and an invaluable supporter in the quest to eradicate mesothelioma as a life-ending disease.
Mesothelioma is a malignant tumor of the lining of the lung, abdomen or heart caused by exposure to asbestos. Medical experts consider it one of the most aggressive of all cancers. For decades the need to develop effective treatments was mostly ignored. Thus, only one FDA approved mesothelioma treatment exists, extending average survival by three months.
The Mesothelioma Applied Research Foundation is the national non-profit dedicated to finding a cure for mesothelioma by funding research, providing education and support for patients, and leading advocacy efforts to increase federal funding for mesothelioma research. To date, the Foundation has funded $6.4 million through its peer-reviewed grant program. The Foundation unites doctors, researchers, patients and families, legal advocates, union representatives, and other affected and concerned individuals to share information and advance mesothelioma research. For more information, visit www.curemeso.org.
Recent Posts in the Same Categories
Most Recent in Full Archive
- Less Invasive Surgery Produces Longer Median Survival in Mesothelioma Patients
- Why Does Asbestos-Related Disease Continue to Rise?
- Targeted Immunotherapy Warrants More Research for Those Suffering from Pleural Mesothelioma
- Understanding the Signs and Symptoms of Asbestos Disease
- New Clinical Trial Underway for Immunotherapy Treatment; CA-170
Most Recent in Mesothelioma Applied Research Foundation (MARF)